Press release
Cell and Gene Therapy Manufacturing Services Market Size, Share, Impressive Industry Growth, Report 2027
The global cell and gene therapy manufacturing services market is anticipated to grow significantly at a CAGR of nearly 11.5% over the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, in 2021, Charles River Laboratories acquired a cell & gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices. The acquisition was intended to increase its cell and gene therapy manufacturing capabilities.A full report of Cell and Gene Therapy Manufacturing Services Market is available at: https://www.omrglobal.com/industry-reports/cell-and-gene-therapy-manufacturing-services-market
In addition to this, in 2021, Thermo Fisher Scientific Inc. acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately $859.7 million. This acquisition is expected to increase its presence in the cell & gene therapy manufacturing therapy market. Further, in 2019, Thermo Fisher Scientific Inc. acquired Brammer Bio, a company involved in viral vector manufacturing for gene and cell therapies, for $1.7 billion.
Apart from this, FUJIFILM Cellular Dynamics opened a $21 million cGMP production facility to support its internal cell therapeutics pipeline, as well as serve as a CDMO for iPS cell products in 2021. Further, Anemocyte announced itself as the first BMO (Biotech Manufacturing Organization) in the field of cell and gene therapies. In addition to building 2000 sq. meters of GMP and GMP-compliant facilities for the production of ATMP’s, its FLYn’ICE project is using drones equipped with cryogenic pods to achieve temperature-controlled transit of cell and gene therapies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-and-gene-therapy-manufacturing-services-market
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- by Therapy, Scale, Indication, and End-User.
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Thermo Fisher Inc, Merck KGaA, and F. Hoffmann-La Roche Ltd. among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Cell and Gene Therapy Manufacturing Services Market – Segmentation
By Therapy
• Cell Therapy
• Gene Therapy
By Scale
• Pre-commercial/ R&D Scale Manufacturing
• Commercial Scale Manufacturing
By Indication
• Cancer
• CVD
• Orthopedic
• Infectious Diseases
• Others
By End-User
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/cell-and-gene-therapy-manufacturing-services-market
Cell and Gene Therapy Manufacturing Services Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• bluebird bio, Inc.
• Boehringer Ingelheim International GmbH
• Catalent, Inc.
• Cell and Gene Therapy Catapult
• Innovative Cellular Therapeutics Co., Ltd.
• Charles River Laboratories International, Inc.
• F. Hoffmann-La Roche Ltd.
• FUJIFILM Holdings Corp.
• Miltenyi Biotec B.V. & Co. KG
• Nikon CeLL innovation Co., Ltd.
• Novartis AG
• Oxford Biomedica plc
• Samsung Biologics
• Takara Bio Inc.
• WuXi AppTec Co., Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Manufacturing Services Market Size, Share, Impressive Industry Growth, Report 2027 here
News-ID: 2480094 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Therapy
Visual Arts Therapy Market Future Business Opportunities 2024-2031 | American Ar …
A recent report titled "Visual Arts Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report additionally features a comprehensive table of contents, figures, tables, and charts, as well as an analysis of the data. The Visual…
Hair Transplant Market by Therapy (Platelet-Rich Plasma Therapy (PRP), Stem Cell …
Hair transplant refers to the market for surgical procedures aimed at restoring hair growth in individuals experiencing hair loss or baldness. These procedures involve the transplantation of hair follicles from one part of the body to the balding or thinning areas.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-hair-transplant-market
The expansion of biotechnology sector across the globe, acts as one of the major factors driving the growth of global hair transplant market. The increase in the…
Melanoma Therapeutics Market By Chemotherapy, Biologic therapy, Targeted therapy …
Melanoma market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapies and combination therapies are expected to…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
